Pinnacle Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Pinnacle Holdings’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,579	Closed	-$93.2K	–	224
2014 Q4	$93.2K	Buy	+1,579	New	+$89K	0.03%	169
2014 Q2	–	Sell	-1,427	Closed	-$74.1K	–	202
2014 Q1	$74.1K	Buy	1,427 +501	+54%	+$26.7K	0.02%	169
2013 Q4	$49.2K	Buy	+926	New	+$47.2K	0.01%	164

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Pinnacle Holdings's BMY Position: Q1 2015 in Review

Pinnacle Holdings sold out of Bristol-Myers Squibb (BMY) in Q1 2015, closing a stake of 1,579 shares — an estimated $93.2K sold.

Pinnacle Holdings first reported a position in BMY in Q4 2013 and held it in 3 quarters. The position peaked at $93.2K in Q4 2014. 1,449 funds tracked by Wall St. Rank hold BMY as of Q1 2015.

Pinnacle Holdings reported no remaining Bristol-Myers Squibb position as of Q1 2015 after selling out during the quarter.
Pinnacle Holdings sold 1,579 Bristol-Myers Squibb shares in Q1 2015, an estimated $93.2K.
Pinnacle Holdings first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 3 quarters.
Pinnacle Holdings's Bristol-Myers Squibb position peaked at $93.2K in Q4 2014.
1,449 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2015.

Based on Pinnacle Holdings's 13F filing for Q1 2015, filed 12 May 2015.